Related Experiment Video
Updated: Jul 3, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
[Therapy of cardiogenic shock after myocardial infarction]
1Klinik für Innere Medizin I, Universitätsklinikum, Friedrich-Schiller-Universität, Erlanger Allee 101, Jena, Germany. markus.ferrari@med.uni-jena.de
Abstract:
The therapy of infarct related cardiogenic shock should primarily focus on fastest possible revascularization. In addition, rapid restoration of sufficient organ perfusion pressure is recommended for the prevention of a multi-organ dysfunction syndrome (MODS). This can be achieved by mechanical circulatory assist devices as well as individual catecholamine therapy. Since assist devices require specially trained physicians, their use is limited to specialized cardiac care centers. However, future technologies such as portable heart-lung-machines may help to further improve transfer to specialized centers and therapy of shock patients.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Myocarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
